ATE239456T1 - Pharmazeutische formulierung in form eines trockenen pulvers - Google Patents

Pharmazeutische formulierung in form eines trockenen pulvers

Info

Publication number
ATE239456T1
ATE239456T1 AT99971707T AT99971707T ATE239456T1 AT E239456 T1 ATE239456 T1 AT E239456T1 AT 99971707 T AT99971707 T AT 99971707T AT 99971707 T AT99971707 T AT 99971707T AT E239456 T1 ATE239456 T1 AT E239456T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulation
dry powder
particles
finely divided
drug particles
Prior art date
Application number
AT99971707T
Other languages
English (en)
Inventor
Karin Malmqvist-Granlund
Gordon Santesson
Eva Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE239456T1 publication Critical patent/ATE239456T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99971707T 1998-11-05 1999-11-03 Pharmazeutische formulierung in form eines trockenen pulvers ATE239456T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803770A SE9803770D0 (sv) 1998-11-05 1998-11-05 Dry powder pharmaceutical formulation
PCT/SE1999/001990 WO2000027373A1 (en) 1998-11-05 1999-11-03 Dry powder pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ATE239456T1 true ATE239456T1 (de) 2003-05-15

Family

ID=20413178

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971707T ATE239456T1 (de) 1998-11-05 1999-11-03 Pharmazeutische formulierung in form eines trockenen pulvers

Country Status (11)

Country Link
US (1) US6391340B1 (de)
EP (1) EP1124544B1 (de)
JP (1) JP4843140B2 (de)
AT (1) ATE239456T1 (de)
AU (1) AU1434700A (de)
DE (1) DE69907717T2 (de)
DK (1) DK1124544T3 (de)
ES (1) ES2198164T3 (de)
PT (1) PT1124544E (de)
SE (1) SE9803770D0 (de)
WO (1) WO2000027373A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
CA2554064A1 (en) * 2004-01-21 2005-08-11 Schering Corporation Treatment methods
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2014007781A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
US10105316B2 (en) 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
US20150165037A1 (en) 2012-07-05 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising corticosteroid and sorbitol
US10111957B2 (en) 2012-07-05 2018-10-30 Arven Ilac Snayi ve Ticaret A.S. Inhalation compositions comprising glucose anhydrous
CA3122396A1 (en) 2018-12-11 2020-06-18 Satsuma Pharmaceuticals, Inc. Compositions, devices, and methods for treating or preventing headaches

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE76311T1 (de) * 1986-08-19 1992-06-15 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
JPS6434919A (en) * 1987-07-30 1989-02-06 Tadahisa Takashima Aerosol preparation for nasal application
GB9101592D0 (en) 1991-01-24 1991-03-06 Glaxo Group Ltd Compositions
DE4140689B4 (de) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
JPH07165613A (ja) 1993-10-19 1995-06-27 Dot:Kk 経鼻吸収薬物用キャリヤおよび生理活性ペプチド組成物
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation

Also Published As

Publication number Publication date
AU1434700A (en) 2000-05-29
EP1124544A1 (de) 2001-08-22
DE69907717T2 (de) 2004-03-04
DE69907717D1 (de) 2003-06-12
US6391340B1 (en) 2002-05-21
ES2198164T3 (es) 2004-01-16
PT1124544E (pt) 2003-09-30
DK1124544T3 (da) 2003-08-04
JP2002529402A (ja) 2002-09-10
SE9803770D0 (sv) 1998-11-05
WO2000027373A1 (en) 2000-05-18
JP4843140B2 (ja) 2011-12-21
EP1124544B1 (de) 2003-05-07

Similar Documents

Publication Publication Date Title
DE69907717D1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
BR9812590A (pt) Composições farmacêuticas de sabor mascarado
ATE286057T1 (de) Pharmazeutische zubereitungen enthaltend clavulansäure
NO973502L (no) Bærerpartikler for anvendelse i törre pulverinhalatorer
AU3102597A (en) Method for providing dense particle compositions for use in transdermal particle delivery
NO20004980D0 (no) Partikulær virkestoffbærer for pulmonær anvendelse
EA200400045A1 (ru) Система для ингаляции сухим порошком для транспульмонарного применения
ES2192866T3 (es) Polvo seco para inhalacion.
CY1107714T1 (el) Φαρμακευτικες συνθεσεις μοδαφινιλιου
EA199900201A1 (ru) Фармацевтическая аэрозольная композиция
ATE364381T1 (de) Formulierungen zur verwendung in inhalationsvorrichtungen
ES2076358T3 (es) Granulados con elevado contenido de ibuprofeno.
DE69925293D1 (de) Sprühbeschichtete mikropartikel für nadellose spritzen
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
SE0003082D0 (sv) Metered electro-dose
ME00530B (me) Farmaceutske kompozicije tizoksanida i nitazoksanida
BR9713886A (pt) Composição anitranspirante em suspensão.
ATE376827T1 (de) Solid darreichungsform enthaltend koffein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1124544

Country of ref document: EP